- Home
- ELVN vs EMAT Comparison
ELVN vs EMAT Comparison
Compare ELVN & EMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ELVN | EMAT |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.4B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ELVN | EMAT |
|---|---|---|
| Price | $58.76 | $3.07 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $43.40 | $30.00 |
| AVG Volume (30 Days) | ★ 1.0M | 163.5K |
| Earning Date | 05-11-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.17 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2,122.43 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.79 | $2.15 |
| 52 Week High | $62.32 | $17.50 |
Technical Indicators
Market Signals| Indicator | ELVN | EMAT |
|---|---|---|
| Relative Strength Index (RSI) | 62.42 | 35.41 |
| Support Level | $25.63 | N/A |
| Resistance Level | $62.32 | $7.62 |
| Average True Range (ATR) | 2.85 | 0.51 |
| MACD | -0.19 | -0.02 |
| Stochastic Oscillator | 64.44 | 31.36 |
Price Performance
Historical ComparisonAbout ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About EMAT Evolution Metals & Technologies Corp. Common Stock
Evolution Metals & Technologies Corp is a critical materials and technology company. The company is focused on developing a secure, dependable, and self-sustaining U.S.-aligned supply chain for critical minerals and materials (CMM), and rare earth elements (REEs). The company is also engaged in recycling end-of-life materials through urban mining to help strengthen domestic resource independence and long-term supply stability.